Selected research
Market Structure
Global AI Drug Discovery Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global AI Drug Discovery Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for AI Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for AI Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for AI Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for AI Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of AI Drug Discovery Software include Merck KGaA, Atomwise Inc, BenevolentAI, BullFrog AI, Genesis Therapeutics, Pharma.AI, Recursion Pharmaceuticals, Verge Genomics and Schrödinger, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global AI Drug Discovery Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of AI Drug Discovery Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents AI Drug Discovery Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI Drug Discovery Software market size, projected growth trends, production technologies, key applications, and end-use industries.
AI Drug Discovery Software Segment by Company
Merck KGaA
Atomwise Inc
BenevolentAI
BullFrog AI
Genesis Therapeutics
Pharma.AI
Recursion Pharmaceuticals
Verge Genomics
Schrödinger, Inc.
XtalPi
Iktos
AI Drug Discovery Software Segment by Type
Cloud Based
On Premise
AI Drug Discovery Software Segment by Application
CRO and Universities
Pharmaceutical Company
Test Lab
AI Drug Discovery Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Discovery Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Drug Discovery Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Discovery Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI Drug Discovery Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Drug Discovery Software industry.
Chapter 3: Detailed analysis of AI Drug Discovery Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Drug Discovery Softwarerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud Based
- On Premise
Applications
- CRO and Universities
- Pharmaceutical Company
- Test Lab
Companies covered
- Merck KGaA
- Atomwise Inc
- BenevolentAI
- BullFrog AI
- Genesis Therapeutics
- Pharma.AI
- Recursion Pharmaceuticals
- Verge Genomics
- Schrödinger, Inc.
- XtalPi
- Iktos
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global AI Drug Discovery Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Cloud Based
- 1.2.3 On Premise
- 1.3 Market Analysis by Application
- 1.3.1 Global AI Drug Discovery Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 CRO and Universities
- 1.3.3 Pharmaceutical Company
- 1.3.4 Test Lab
- 1.4 Global Market Growth Prospects
- 1.5 Global AI Drug Discovery Software Growth Trends by Region
- 1.5.1 Global AI Drug Discovery Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 AI Drug Discovery Software Market Size by Region (2021-2026)
- 1.5.3 AI Drug Discovery Software Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global AI Drug Discovery Software Market Dynamics
- 2.1 AI Drug Discovery Software Industry Trends
- 2.2 AI Drug Discovery Software Industry Drivers
- 2.3 AI Drug Discovery Software Industry Opportunities and Challenges
- 2.4 AI Drug Discovery Software Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global AI Drug Discovery Software Revenue by Company (2021-2026)
- 3.2 Global AI Drug Discovery Software Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global AI Drug Discovery Software Key Company Head office and Area Served
- 3.4 Global AI Drug Discovery Software Company, Product Type & Application
- 3.5 Global AI Drug Discovery Software Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global AI Drug Discovery Software Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 AI Drug Discovery Software Players Market Share by Revenue in 2025
- 3.6.3 2025 AI Drug Discovery Software Tier 1, Tier 2, and Tier 3
4 AI Drug Discovery Software Market by Type
- 4.1 Global AI Drug Discovery Software Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global AI Drug Discovery Software Market Size by Type (2021-2032)
- 4.3 Global AI Drug Discovery Software Market Size Share by Type (2021-2032)
5 AI Drug Discovery Software Market by Application
- 5.1 Global AI Drug Discovery Software Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global AI Drug Discovery Software Market Size by Application (2021-2032)
- 5.3 Global AI Drug Discovery Software Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Merck KGaA
- 6.1.1 Merck KGaA Company Information
- 6.1.2 Merck KGaA Business Overview
- 6.1.3 Merck KGaA AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Merck KGaA AI Drug Discovery Software Product Portfolio
- 6.1.5 Merck KGaA Recent Developments
- 6.2 Atomwise Inc
- 6.2.1 Atomwise Inc Company Information
- 6.2.2 Atomwise Inc Business Overview
- 6.2.3 Atomwise Inc AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Atomwise Inc AI Drug Discovery Software Product Portfolio
- 6.2.5 Atomwise Inc Recent Developments
- 6.3 BenevolentAI
- 6.3.1 BenevolentAI Company Information
- 6.3.2 BenevolentAI Business Overview
- 6.3.3 BenevolentAI AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 BenevolentAI AI Drug Discovery Software Product Portfolio
- 6.3.5 BenevolentAI Recent Developments
- 6.4 BullFrog AI
- 6.4.1 BullFrog AI Company Information
- 6.4.2 BullFrog AI Business Overview
- 6.4.3 BullFrog AI AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 BullFrog AI AI Drug Discovery Software Product Portfolio
- 6.4.5 BullFrog AI Recent Developments
- 6.5 Genesis Therapeutics
- 6.5.1 Genesis Therapeutics Company Information
- 6.5.2 Genesis Therapeutics Business Overview
- 6.5.3 Genesis Therapeutics AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Genesis Therapeutics AI Drug Discovery Software Product Portfolio
- 6.5.5 Genesis Therapeutics Recent Developments
- 6.6 Pharma.AI
- 6.6.1 Pharma.AI Company Information
- 6.6.2 Pharma.AI Business Overview
- 6.6.3 Pharma.AI AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Pharma.AI AI Drug Discovery Software Product Portfolio
- 6.6.5 Pharma.AI Recent Developments
- 6.7 Recursion Pharmaceuticals
- 6.7.1 Recursion Pharmaceuticals Company Information
- 6.7.2 Recursion Pharmaceuticals Business Overview
- 6.7.3 Recursion Pharmaceuticals AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Recursion Pharmaceuticals AI Drug Discovery Software Product Portfolio
- 6.7.5 Recursion Pharmaceuticals Recent Developments
- 6.8 Verge Genomics
- 6.8.1 Verge Genomics Company Information
- 6.8.2 Verge Genomics Business Overview
- 6.8.3 Verge Genomics AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Verge Genomics AI Drug Discovery Software Product Portfolio
- 6.8.5 Verge Genomics Recent Developments
- 6.9 Schrödinger, Inc.
- 6.9.1 Schrödinger, Inc. Company Information
- 6.9.2 Schrödinger, Inc. Business Overview
- 6.9.3 Schrödinger, Inc. AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Schrödinger, Inc. AI Drug Discovery Software Product Portfolio
- 6.9.5 Schrödinger, Inc. Recent Developments
- 6.10 XtalPi
- 6.10.1 XtalPi Company Information
- 6.10.2 XtalPi Business Overview
- 6.10.3 XtalPi AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 XtalPi AI Drug Discovery Software Product Portfolio
- 6.10.5 XtalPi Recent Developments
- 6.11 Iktos
- 6.11.1 Iktos Company Information
- 6.11.2 Iktos Business Overview
- 6.11.3 Iktos AI Drug Discovery Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Iktos AI Drug Discovery Software Product Portfolio
- 6.11.5 Iktos Recent Developments
7 North America
- 7.1 North America AI Drug Discovery Software Market Size (2021-2032)
- 7.2 North America AI Drug Discovery Software Market Size by Type
- 7.2.1 North America AI Drug Discovery Software Market Size by Type (2021-2026)
- 7.2.2 North America AI Drug Discovery Software Market Size by Type (2027-2032)
- 7.2.3 North America AI Drug Discovery Software Market Share by Type (2021-2032)
- 7.3 North America AI Drug Discovery Software Market Size by Application
- 7.3.1 North America AI Drug Discovery Software Market Size by Application (2021-2026)
- 7.3.2 North America AI Drug Discovery Software Market Size by Application (2027-2032)
- 7.3.3 North America AI Drug Discovery Software Market Share by Application (2021-2032)
- 7.4 North America AI Drug Discovery Software Market Size by Country
- 7.4.1 North America AI Drug Discovery Software Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America AI Drug Discovery Software Market Size by Country (2021-2026)
- 7.4.3 North America AI Drug Discovery Software Market Size by Country (2027-2032)
- 7.4.4 North America AI Drug Discovery Software Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe AI Drug Discovery Software Market Size (2021-2032)
- 8.2 Europe AI Drug Discovery Software Market Size by Type
- 8.2.1 Europe AI Drug Discovery Software Market Size by Type (2021-2026)
- 8.2.2 Europe AI Drug Discovery Software Market Size by Type (2027-2032)
- 8.2.3 Europe AI Drug Discovery Software Market Share by Type (2021-2032)
- 8.3 Europe AI Drug Discovery Software Market Size by Application
- 8.3.1 Europe AI Drug Discovery Software Market Size by Application (2021-2026)
- 8.3.2 Europe AI Drug Discovery Software Market Size by Application (2027-2032)
- 8.3.3 Europe AI Drug Discovery Software Market Share by Application (2021-2032)
- 8.4 Europe AI Drug Discovery Software Market Size by Country
- 8.4.1 Europe AI Drug Discovery Software Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe AI Drug Discovery Software Market Size by Country (2021-2026)
- 8.4.3 Europe AI Drug Discovery Software Market Size by Country (2027-2032)
- 8.4.4 Europe AI Drug Discovery Software Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China AI Drug Discovery Software Market Size (2021-2032)
- 9.2 China AI Drug Discovery Software Market Size by Type
- 9.2.1 China AI Drug Discovery Software Market Size by Type (2021-2026)
- 9.2.2 China AI Drug Discovery Software Market Size by Type (2027-2032)
- 9.2.3 China AI Drug Discovery Software Market Share by Type (2021-2032)
- 9.3 China AI Drug Discovery Software Market Size by Application
- 9.3.1 China AI Drug Discovery Software Market Size by Application (2021-2026)
- 9.3.2 China AI Drug Discovery Software Market Size by Application (2027-2032)
- 9.3.3 China AI Drug Discovery Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia AI Drug Discovery Software Market Size (2021-2032)
- 10.2 Asia AI Drug Discovery Software Market Size by Type
- 10.2.1 Asia AI Drug Discovery Software Market Size by Type (2021-2026)
- 10.2.2 Asia AI Drug Discovery Software Market Size by Type (2027-2032)
- 10.2.3 Asia AI Drug Discovery Software Market Share by Type (2021-2032)
- 10.3 Asia AI Drug Discovery Software Market Size by Application
- 10.3.1 Asia AI Drug Discovery Software Market Size by Application (2021-2026)
- 10.3.2 Asia AI Drug Discovery Software Market Size by Application (2027-2032)
- 10.3.3 Asia AI Drug Discovery Software Market Share by Application (2021-2032)
- 10.4 Asia AI Drug Discovery Software Market Size by Country
- 10.4.1 Asia AI Drug Discovery Software Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia AI Drug Discovery Software Market Size by Country (2021-2026)
- 10.4.3 Asia AI Drug Discovery Software Market Size by Country (2027-2032)
- 10.4.4 Asia AI Drug Discovery Software Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa AI Drug Discovery Software Market Size (2021-2032)
- 11.2 South America, Middle East & Africa AI Drug Discovery Software Market Size by Type
- 11.2.1 South America, Middle East & Africa AI Drug Discovery Software Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa AI Drug Discovery Software Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa AI Drug Discovery Software Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa AI Drug Discovery Software Market Size by Application
- 11.3.1 South America, Middle East & Africa AI Drug Discovery Software Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa AI Drug Discovery Software Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa AI Drug Discovery Software Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa AI Drug Discovery Software Market Size by Country
- 11.4.1 South America, Middle East & Africa AI Drug Discovery Software Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa AI Drug Discovery Software Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa AI Drug Discovery Software Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa AI Drug Discovery Software Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst